Validation of a Nomogram for Predicting the Probability of Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasm in 180 Pancreatic Resection Patients at 3 High-Volume Centers
Yasuhiro Shimizu(Aichi Cancer Center), Akio Yanagisawa(Kyoto first Red Cross hospital), Yukihide Kanemitsu(National Cancer Center), Hiroyuki Maguchi(Teine Keijinkai Hospital), Manabu Osanai, Yoshiki Senda, Hiroki Yamaue(Wakayama Medical University), Kenji Yamao(Aichi Cancer Center), Susumu Hijioka(Aichi Cancer Center), Vikram Bhatia(Institute of Liver and Biliary Sciences), Tsuyoshi Sano(Aichi Medical University), Seiko Hirono(Wakayama Medical University)
Cited by 45
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600